Kết quả tìm kiếm - Rosalind Graham

  • Đang hiển thị 1 - 11 kết quả của 11
Tinh chỉnh kết quả
  1. 1
    Human endometrial MUC1 carries keratan sulfate: characteristic glycoforms in the luminal epithelium at receptivity

    Human endometrial MUC1 carries keratan sulfate: characteristic glycoforms in the luminal epithelium at receptivity Bằng John Aplin, Neil A. Hey, Rosalind Graham

    Được phát hành 1998
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    Latest developments in MUC1 immunotherapy

    Latest developments in MUC1 immunotherapy Bằng Joyce Taylor‐Papadimitriou, Joy Burchell, Rosalind Graham, Richard Beatson

    Được phát hành 2018
    lấy văn bản lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    O-linked mucin-type glycosylation in breast cancer

    O-linked mucin-type glycosylation in breast cancer Bằng Joy Burchell, Richard Beatson, Rosalind Graham, Joyce Taylor‐Papadimitriou, Virginia Tajadura‐Ortega

    Được phát hành 2018
    lấy văn bản lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer

    A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer Bằng D.W. Miles, KE Towlson, Rosalind Graham, MA Reddish, BM Longenecker, Joyce Taylor‐Papadimitriou, RD Rubens

    Được phát hành 1996
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  5. 5
    Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells

    Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells Bằng Malin Bäckström, Thomas A. Link, Fredrik J. Olson, Hasse Karlsson, Rosalind Graham, Gianfranco Picco, Joy Burchell, Joyce Taylor‐Papadimitriou, Thomas Noll, Gunnar C. Hansson

    Được phát hành 2003
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  6. 6
    Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype

    Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype Bằng Richard Beatson, Rosalind Graham, Fabio Grundland Freile, Domenico Cozzetto, Shichina Kannambath, Ester Pfeifer, Natalie Woodman, Julie Owen, Rosamond Nuamah, Ulla Mandel, Sarah E. Pinder, Cheryl Gillett, Thomas Noll, Ihssane Bouybayoune, Joyce Taylor‐Papadimitriou, Joy Burchell

    Được phát hành 2020
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  7. 7
    Serum-derived extracellular vesicles from breast cancer patients contribute to differential regulation of T-cell-mediated immune-escape mechanisms in breast cancer subtypes

    Serum-derived extracellular vesicles from breast cancer patients contribute to differential regulation of T-cell-mediated immune-escape mechanisms in breast cancer subtypes Bằng Rosalind Graham, Patrycja Gazińska, Birong Zhang, Atousa Khiabany, Shubhankar Sinha, Thanussuyah Alaguthurai, Fabián Flores-Borja, José M. Vicencio, Fabienne Beuron, Ioannis Roxanis, Rafał Matkowski, Revadee Liam‐Or, Andrew Tutt, Tony Ng, Khuloud T. Al‐Jamal, You Zhou, Sheeba Irshad

    Được phát hành 2023
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  8. 8
    Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer

    Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer Bằng Brian Burford, A. Gentry-Maharaj, Rosalind Graham, DS Allen, J. Pedersen, Aaron S. Nudelman, Ola Blixt, Evangelia-O Fourkala, Deanna Bueti, Anne Dawnay, Jane B. Ford, Roopal Desai, Leonor David, Peter Trinder, Bruce Acres, Tilo Schwientek, Alex Gammerman, Celso A. Reis, Luísa Silva, Hugo Osório, Rachel Hallett, Hans H. Wandall, Ulla Mandel, Michael A. Hollingsworth, Ian Jacobs, Ian S. Fentiman, Henrik Clausen, Joyce Taylor‐Papadimitriou, Usha Menon, Joy Burchell

    Được phát hành 2013
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  9. 9
    Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer

    Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer Bằng Duncan R. McKenzie, Miguel Muñoz‐Ruiz, Leticia Monin, Thanussuyah Alaguthurai, Thomas Lechmere, Sultan Abdul-Jawad, Carl Graham, Emily Pollock, Rosalind Graham, Kamila Sychowska, Jeffrey Seow, Catherine Tremain, Charalampos Gousis, Clara Domingo‐Vila, Jack Cooper, Jennifer Vidler, Kasia Owczarczyk, Angela Swampillai, Hartmut Kristeleit, Michael H. Malim, Paul Fields, Piers Patten, Sophie Papa, Bernard V. North, Timothy Tree, Katie J. Doores, Adrian Hayday, Sheeba Irshad

    Được phát hành 2021
    lấy văn bản
    Carta
    Lưu vào danh sách
    Đã lưu trong:
  10. 10
    Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines

    Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines Bằng Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz, Duncan R. McKenzie, Irene del Molino del Barrio, Thanussuyah Alaguthurai, Clara Domingo‐Vila, Thomas S. Hayday, Carl Graham, Jeffrey Seow, Sultan Abdul-Jawad, Shraddha Kamdar, Elizabeth Harvey-Jones, Rosalind Graham, Jack Cooper, Muhammad Khan, Jennifer Vidler, Helen Kakkassery, Sinha Shubhankar, Richard Davis, Liane Dupont, Isaac Francos-Quijorna, Puay Lee, Josephine Eum, Maria Conde Poole, Magdalene Joseph, Daniel Davies, Yin Wu, Ana Montes, Mark Harries, Anne Rigg, James Spicer, Michael H. Malim, Paul Fields, Piers Patten, Francesca Di Rosa, Sophie Papa, Timothy Tree, Katie J. Doores, Adrian Hayday, Sheeba Irshad

    Được phát hành 2021
    lấy văn bản
    Pré-impressão
    Lưu vào danh sách
    Đã lưu trong:
  11. 11
    Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

    Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study Bằng Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz, Duncan R. McKenzie, Irene del Molino del Barrio, Thanussuyah Alaguthurai, Clara Domingo‐Vila, Thomas S. Hayday, Carl Graham, Jeffrey Seow, Sultan Abdul-Jawad, Shraddha Kamdar, Elizabeth Harvey-Jones, Rosalind Graham, Jack Cooper, Muhammad Khan, Jennifer Vidler, Helen Kakkassery, Shubhankar Sinha, Richard Davis, Liane Dupont, Isaac Francos-Quijorna, Charlotte O’Brien-Gore, Puay Ling Lee, Josephine Eum, Maria Conde Poole, Magdalene Joseph, Daniel Davies, Yin Wu, Angela Swampillai, Bernard V. North, Ana Montes, Mark Harries, Anne Rigg, James Spicer, Michael H. Malim, Paul Fields, Piers Patten, Francesca Di Rosa, Sophie Papa, Timothy Tree, Katie J. Doores, Adrian Hayday, Sheeba Irshad

    Được phát hành 2021
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: